Literature DB >> 84151

Growth-stimulating factor in regenerating canine liver.

T E Starzl, A F Jones, J Terblanche, S Usui, K A Porter, G Mazzoni.   

Abstract

Extracts from dog livers which had been regenerating for 24, 48, and 72 h after hepatectomy were infused for 6 h into the left portal vein of animals which had fresh portacaval shunts (Eck fistula) and which were killed 2 and 3 days later. The brief exposure to the 48-h and especially the 72-h regenerating liver extracts induced a delayed proliferative response predominantly in the left liver lobes, with a slight spillover effect to the right liver lobes but none to the kidney. The response reached its peak 3 days later. In the left but not the right liver lobes, both the 48-h and the 72-h regenerating liver extract reversed the atrophy ordinarily caused by Eck fistula in 3 days and partly prevented the ultrastructural hepatocyte deterioration characteristic of Eck fistula. The active liver extracts apparently contained a growth-control factor or factors which is (are) not insulin or glucagon.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 84151      PMCID: PMC2978530          DOI: 10.1016/s0140-6736(79)90519-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  19 in total

1.  Insulin, glucagon, and the liver.

Authors:  N L Bucher
Journal:  Adv Enzyme Regul       Date:  1976

2.  Regeneration of the liver.

Authors:  K WEINBREN
Journal:  Gastroenterology       Date:  1959-11       Impact factor: 22.682

3.  The presence of a mitosis inhibitor in the serum and liver of adult rats.

Authors:  H F STICH; M L FLORIAN
Journal:  Can J Biochem Physiol       Date:  1958-08

4.  Mitotic activity and growth factors in the liver of the white rat.

Authors:  H TEIR; K RAVANTI
Journal:  Exp Cell Res       Date:  1953-12       Impact factor: 3.905

5.  The effect of splanchnic viscera removal upon canine liver regeneration.

Authors:  T E Starzl; A Francavilla; K A Porter; J Benichou; A F Jones
Journal:  Surg Gynecol Obstet       Date:  1978-08

6.  Some observations on liver cell proliferation in the isolated perfused rat liver.

Authors:  E A Lloyd; N Crozier; G Pamphlet; M Wells; S J Saunders
Journal:  Br J Exp Pathol       Date:  1974-06

7.  Preparation and partial characterization of hepatic regenerative stimulator substance (SS) from rat liver.

Authors:  D R LaBrecque; L A Pesch
Journal:  J Physiol       Date:  1975-06       Impact factor: 5.182

8.  Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs.

Authors:  T E Starzl; K Watanabe; K A Porter; C W Putnam
Journal:  Lancet       Date:  1976-04-17       Impact factor: 79.321

9.  GROWTH INHIBITION BY SUBSTANCES IN LIVER.

Authors:  A M Brues; Y Subbarow; E B Jackson; J C Aub
Journal:  J Exp Med       Date:  1940-03-31       Impact factor: 14.307

10.  A quantitative stereological description of the ultrastructure of normal rat liver parenchymal cells.

Authors:  A V Loud
Journal:  J Cell Biol       Date:  1968-04       Impact factor: 10.539

View more
  40 in total

1.  History of clinical transplantation.

Authors:  T E Starzl
Journal:  World J Surg       Date:  2000-07       Impact factor: 3.352

2.  Effect on the canine Eck fistula liver of intraportal TGF-beta alone or with hepatic growth factors.

Authors:  A Francavilla; A Azzarone; G Carrieri; C Scotti-Foglieni; Q H Zeng; U Cillo; K Porter; T E Starzl
Journal:  Hepatology       Date:  1992-11       Impact factor: 17.425

Review 3.  Hepatic stimulator substance. Discovery, characteristics and mechanism of action.

Authors:  D R LaBrecque
Journal:  Dig Dis Sci       Date:  1991-05       Impact factor: 3.199

4.  Isolation and Partial Purification of Hepatic Stimulatory Substance.

Authors:  A Francavilla; P Ove; L Polimeno; M Coetzee; L Makowka; M Barone; D H Van Thiel; T E Starzl
Journal:  Transplant Proc       Date:  1988-02       Impact factor: 1.066

5.  Studies of the hepatotrophic qualities of FK 506 and CyA.

Authors:  V Mazzaferro; C L Scotti-Foglieni; K A Porter; J Trejo Bellido; G Carrieri; S Todo; J J Fung; A Francavilla; T E Starzl
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

6.  Hepatotrophic effects of FK506 in dogs.

Authors:  T E Starzl; K A Porter; V Mazzaferro; S Todo; J Fung; A Francavilla
Journal:  Transplantation       Date:  1991-01       Impact factor: 4.939

7.  Cholera toxin-sensitive GTP-binding protein-coupled activation of augmenter of liver regeneration (ALR) receptor and its function in rat kupffer cells.

Authors:  Chandrashekhar R Gandhi; Noriko Murase; Thomas E Starzl
Journal:  J Cell Physiol       Date:  2010-02       Impact factor: 6.384

8.  The characterization and partial purification of hepatocyte proliferation factor.

Authors:  L C Schwarz; L Makowka; J A Falk; R Falk
Journal:  Ann Surg       Date:  1985-09       Impact factor: 12.969

9.  Induction of hepatocyte stimulating activity by T3 and appearance of the activity despite inhibition of DNA synthesis by adriamycin.

Authors:  A Francavilla; P Ove; D H Van Thiel; M L Coetzee; S K Wu; A DiLeo; T E Starzl
Journal:  Horm Metab Res       Date:  1984-05       Impact factor: 2.936

10.  The effect of hepatic stimulatory substance, isolated from regenerating hepatic cytosol, and 50,000 and 300,000 subfractions in enhancing survival in experimental acute hepatic failure in rats treated with D-galactosamine.

Authors:  A Francavilla; A DiLeo; L Polimeno; J Gavaler; R Pellicci; S Todo; I Kam; J Prelich; L Makowka; T E Starzl
Journal:  Hepatology       Date:  1986 Nov-Dec       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.